According to INmune Bio's latest financial reports the company's current EPS (TTM) is -HK$14.06. In 2022 the company made an earnings per share (EPS) of -HK$11.80 an increase over its 2021 EPS that were of -HK$14.60.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -HK$14.18 | |
2022 | -HK$11.80 | -19.15% |
2021 | -HK$14.60 | 86.14% |
2020 | -HK$7.84 | 34.67% |
2019 | -HK$5.82 | -32.36% |
2018 | -HK$8.61 | 1396.12% |
2017 | -HK$0.58 | 199.64% |
2016 | -HK$0.19 |